Efficacy and safety of intravitreal fluocinolone acetonide implant for chronic diabetic macular edema previously treated in real-life practice: the realfac study

HIGHLIGHTS

  • who: Thibaud Mathis and colleagues from the UMR-CNRS , Matéis, Université Lyon, Villeurbanne, France have published the Article: Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study, in the Journal: Pharmaceutics 2022, 14, 723. of /2022/
  • what: This study evaluates the functional and anatomical efficacy of the FAc implant in real-life practice. This study showed an improvement in mean BCVA which started at 3 months and remained stable during the follow-up period. Unlike previous reports in the literature, the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?